Episode 11 (March 1, 2024): After being diverted by the SARS-CoV-2 pandemic to develop and manufacture COVID-19 vaccines, Moderna gets back to advancing rare disease mRNA therapeutics; a look at rare autoimmune diseases that fly below the public radar; Form Bio announced a partnership with Ginkgo Bioworks to bring their AI out of the computer and into gene therapy production by optimizing genetic payloads.
Listed below are key references to the GEN stories, media, and other items discussed in this episode of Touching Base:
Rare Disease Day: Moderna Gets Back to Its Roots
By Jonathan D. Grinstein, GEN, February 28, 2024
Taming the Immune System When Rare Diseases Strike
By Kathy Liszewski, GEN, February 27, 2024
Form Bio’s AI Ensures Gene Therapies Pass Muster, with Ginkgo’s Help
GEN, February 28, 2024
